Next Article in Journal
Effects of Constant Magnetic Field to the Proliferation Rate of Human Fibroblasts Grown onto Different Substrates: Tissue Culture Polystyrene, Polyacrylamide Hydrogel and Ferrogels γ-Fe2O3 Magnetic Nanoparticles
Next Article in Special Issue
Polydopamine-Coated Laponite Nanoplatforms for Photoacoustic Imaging-Guided Chemo-Phototherapy of Breast Cancer
Previous Article in Journal
DNA Origami Nano-Sheets and Nano-Rods Alter the Orientational Order in a Lyotropic Chromonic Liquid Crystal
Previous Article in Special Issue
Solid Plasmonic Substrates for Breast Cancer Detection by Means of SERS Analysis of Blood Plasma
Review

Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates

1
Department of Chemistry, Shahid Bahonar University of Kerman, Kerman 7616914111, Iran
2
Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
3
Department of Physics, Faculty of Science, University of Zabol, Zabol 538-98615, Iran
4
Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan
5
Department of Chemistry, International Hellenic University, 65404 Kavala, Greece
*
Authors to whom correspondence should be addressed.
Nanomaterials 2020, 10(9), 1696; https://doi.org/10.3390/nano10091696
Received: 17 July 2020 / Revised: 26 August 2020 / Accepted: 26 August 2020 / Published: 28 August 2020
(This article belongs to the Special Issue Application of Nanoscale Materials for Cancer Diagnostic and Therapy)
The fabrication and development of nanomaterials for the treatment of prostate cancer have gained significant appraisal in recent years. Advancements in synthesis of organic and inorganic nanomaterials with charge, particle size, specified geometry, ligand attachment etc have resulted in greater biocompatibility and active targeting at cancer site. Despite all of the advances made over the years in discovering drugs, methods, and new biomarkers for cancer of the prostate (PCa), PCa remains one of the most troubling cancers among people. Early on, effective diagnosis is an essential part of treating prostate cancer. Prostate-specific antigen (PSA) or serum prostate-specific antigen is the best serum marker widely accessible for diagnosis of PCa. Numerous efforts have been made over the past decade to design new biosensor-based strategies for biomolecules detection and PSA miniaturization biomarkers. The growing nanotechnology is expected to have a significant effect in the immediate future on scientific research and healthcare. Nanotechnology is thus predicted to find a way to solve one of the most and long-standing problem, “early cancer detection”. For early diagnosis of PCa biomarkers, different nanoparticles with different approaches have been used. In this review, we provide a brief description of the latest achievements and advances in the use of nanoparticles for PCa biomarker diagnosis. View Full-Text
Keywords: nanomaterials; cancer; prostate; treatment; diagnosis nanomaterials; cancer; prostate; treatment; diagnosis
Show Figures

Figure 1

MDPI and ACS Style

Barani, M.; Sabir, F.; Rahdar, A.; Arshad, R.; Kyzas, G.Z. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates. Nanomaterials 2020, 10, 1696. https://doi.org/10.3390/nano10091696

AMA Style

Barani M, Sabir F, Rahdar A, Arshad R, Kyzas GZ. Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates. Nanomaterials. 2020; 10(9):1696. https://doi.org/10.3390/nano10091696

Chicago/Turabian Style

Barani, Mahmood, Fakhara Sabir, Abbas Rahdar, Rabia Arshad, and George Z. Kyzas 2020. "Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates" Nanomaterials 10, no. 9: 1696. https://doi.org/10.3390/nano10091696

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop